Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
Neuro-Oncology · 2024
DOI: 10.1093/neuonc/noae045 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Alice Morin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Children and Adolescents Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, France. Hauptthemen laut MEDLINE: Optic Nerve Glioma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Gustave Roussy Foundatio, The Fondation ARC, French Society of Childhood and Adolescent Cancer.
Abstract (Originalsprache)
Background
Optic pathway gliomas (OPGs) represent 5% of childhood brain tumors. Successive relapses lead to multiple treatments exposing to late complications.
Methods
We included patients treated at Gustave Roussy (GR) between January 1980 and December 2015 for OPG, before 18 years old and alive at 5 years from diagnosis. Mortality and physical health conditions data were extracted from medical data files and updated, thanks to the GR long-term follow-up program and French national mortality registry for patients included in the French Childhood Cancer Survivor Study.
Results
We included 182 5-year OPG-childhood survivors in the analysis (sex ratio M/F 0.8, 35% with neurofibromatosis type 1 [NF1]). With a median follow-up of 17.2 years (range = 5–41), we registered 82 relapses, 9 second malignancies, and 15 deaths as first events after 5 years, resulting in 20-year conditional overall survival (C-OS) and late events-free survival of 79.9% (95% confidence interval [CI] = 71–86) and 43.5% (95% CI = 36–51), respectively. Radiotherapy exposure in NF1 patients (hazard ratio [HR] = 6, 95% CI = 1.7–21.2) and hypothalamic involvement (HR = 3.2, 95% CI = 1.4–7.3) were significantly associated with C-OS in multivariable analyses. Ninety-five percent of 5-year OPG survivors suffered from any health condition, especially visual acuity “<1/10” (n = 109), pituitary deficiency (n = 106), and neurocognitive impairment (n = 89). NF1 (HR 2.1) was associated with precocious puberty. With a median time post-diagnosis of 4.2 years, 33 cerebrovascular events were observed in 21 patients.
Conclusions
Late relapses, second malignancies, and cerebrovascular diseases are severe late events resulting in premature mortality. Morbidity is high and needs after-cancer care to improve quality of life. Risk factors could be considered to better stratify long-term follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Children and Adolescents Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, France.
- Radiation Epidemiology Group, INSERM Unit 1018, Villejuif, France.
- Paris-Saclay University, Villejuif, France.
- Gustave Roussy, Villejuif, France.
- Department of Pediatric Endocrinology, Diabetology and Gynaecology, Necker-Enfants Malades University Hospital, Paris cite University, Paris, France.
- Department of Endocrinology and Reproductive Medicine, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France.
ORCID-Profile: Alice Morin, Dulanjalee Kariyawasam, Philippe Touraine, Kevin Beccaria, Christelle Dufour, Florent De Vathaire, Jacques Grill, Brice Fresneau
Förderung
- The Gustave Roussy Foundatio
- The Fondation ARC
- French Society of Childhood and Adolescent Cancer
Zitieren
APA
Morin, A., Allodji, R., Kariyawasam, D., Touraine, P., Puget, S., Beccaria, K., De Carli, E., Kieffer, V., Rivollet, S., Abbou, S., Fayech, C., Souchard, V., Dufour, C., De Vathaire, F., Bolle, S., Grill, J., & Fresneau, B. (2024). Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae045
Vancouver
Morin A, Allodji R, Kariyawasam D, Touraine P, Puget S, Beccaria K, et al. Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study. Neuro-Oncology. 2024. doi:10.1093/neuonc/noae045
BibTeX
@article{Morin2024,
author = {Morin, Alice and Allodji, Rodrigue and Kariyawasam, Dulanjalee and Touraine, Philippe and Puget, Stéphanie and Beccaria, Kevin and De Carli, Emilie and Kieffer, Virginie and Rivollet, Sophie and Abbou, Samuel and Fayech, Chiraz and Souchard, Vincent and Dufour, Christelle and De Vathaire, Florent and Bolle, Stéphanie and Grill, Jacques and Fresneau, Brice},
title = {Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study},
journal = {Neuro-Oncology},
year = {2024},
doi = {10.1093/neuonc/noae045}
}
EUVIMED